Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Some users have claimed to experience side effects such as nausea, vomiting, and digestive issues
REWIND expanded the evidence base by studying dulaglutide (1.5 mg/week subcutaneous) in a broader population that included a substantial proportion of primary prevention patientsonly 31% of its 9,903 participants had established cardiovascular disease at baseline [3]
For a full overview of DSIPs background and research insights, check out our main DSIP Nasal Spray page
Avoiding processed foods and alcohol reduces stomach irritation
Remember that medication adjustments should only be made under medical supervisiondo not stop or alter your GLP-1 therapy without consulting your prescriber, as this may affect your diabetes control or weight management goals
Response to letter regarding article, Heart failure, saxagliptin and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial
US$ 20.81
US$ 20.89
US$ 21.84
US$ 22.40
US$ 28.95
US$ 23.05
US$ 20.55
